NEW YORK STATE COMMON RETIREMENT FUND

Pension

Position in ELVN — Enliven Therapeutics, Inc.

CIK 810265 ALBANY, NY

Position in ELVN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$3,407,913

+$1,892,912 QoQ

Shares Held

67,151

+73.8% QoQ

Ownership

0.092%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#91

of 208 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NEW YORK STATE COMMON RETIREMENT FUND holds $953,600,073 across 287 Biotechnology names. ELVN ranks #44 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	277,614	$137,899,202
2	REGN	Regeneron Pharmaceuticals, Inc.	111,369	$69,443,026
3	ASND	Ascendis Pharma A/S	191,791	$51,154,495
4	MDGL	Madrigal Pharmaceuticals, Inc.	94,743	$50,872,253
5	LGND	Ligand Pharmaceuticals Inc	137,258	$43,385,881
6	IONS	Ionis Pharmaceuticals Inc	500,050	$39,648,964
7	INSM	INSMED Inc	304,236	$32,437,642
8	MIRM	Mirum Pharmaceuticals, Inc.	250,558	$29,332,825

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,407,913	67,151	+73.8%	Shares	Sole	2026-07-29
2026-03-31	$1,515,001	38,648	+324.8%	Shares	Sole	2026-05-06
2025-12-31	$140,093	9,097	-39.7%	Shares	Sole	2026-02-12
2025-09-30	$309,035	15,097	+54.1%	Shares	Sole	2025-11-03
2025-06-30	$196,527	9,797	0.0%	Shares	Sole	2025-10-08
2025-03-31	$192,804	9,797	-60.8%	Shares	Sole	2025-10-08
2024-12-31	$563,017	25,023	-9.0%	Shares	Sole	2025-10-08
2024-09-30	$702,630	27,511	+18.7%	Shares	Sole	2025-10-08
2024-06-30	$541,482	23,170	+147.1%	Shares	Sole	2025-10-08
2024-03-31	$164,906	9,375	-0.3%	Shares	Sole	2025-10-08
2023-12-31	$130,082	9,399	-0.6%	Shares	Sole	2025-10-08
2023-09-30	$129,127	9,453	+2.8%	Shares	Sole	2025-10-08
2023-06-30	$187,772	9,200	—	Shares	Sole	2025-10-08
No filing history on record for this holder in this stock.